Assessing fibromyalgia-related fatigue: Content validity and psychometric performance of the Fatigue Visual Analogue Scale in adult patients with fibromyalgia

Clinical and Experimental Rheumatology

Volumn 29, Issue 6 SUPPL. 69, 2011, Pages

  Crawford, B K ^a   Piault, E C ^a   Lai, C ^b   Bennett, R M ^c  

^a MAPI VALUES   (United States)

^b Jazz Pharmaceuticals Inc   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Fatigue; Fibromyalgia; Outcome assessment (health care)

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; FATIGUE; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; GENERAL CONDITION IMPROVEMENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEMI STRUCTURED INTERVIEW; SHORT FORM 36; VISUAL ANALOG SCALE; CHRONIC FATIGUE SYNDROME; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEALTH STATUS; INTERVIEW; METHODOLOGY; MIDDLE AGED; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; SICKNESS IMPACT PROFILE; SYNDROME; VALIDATION STUDY;

ANALGESIC AGENT; OXYBATE SODIUM;

ADULT; AGED; ANALGESICS; CHRONIC PAIN; FATIGUE SYNDROME, CHRONIC; FEMALE; FIBROMYALGIA; HEALTH STATUS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PAIN MEASUREMENT; PSYCHOMETRICS; SICKNESS IMPACT PROFILE; SODIUM OXYBATE; SYNDROME;

EID: 84858842876     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. BRANCO JC, BANNWARTH B, FAILDE I et al.: Prevalence of Fibromyalgia: A Survey in Five European Countries. Semin Arthritis Rheum 2009.
2. WOLFE F, ROSS K, ANDERSON J, RUSSELL IJ, HEBERT L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
3. GOLDENBERG DL, BURCKHARDT C, CROFFORD L: Management of fibromyalgia syndrome. JAMA 2004;292:2388-95. (Pubitemid 39491924)
4. WOLFE F, SMYTHE HA, YUNUS MB et al.: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72. (Pubitemid 20098653)
5. BERNARD AL, PRINCE A, EDS ALL P: Quality of life issues for fibromyalgia patients. Arthritis Care Res 2000;13:42-50.
6. MEASE PJ, ARNOLD LM, CROFFORD LJ et al.: Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum 2008;59:952-60. (Pubitemid 351990991)
7. MEASE P, ARNOLD LM, CHOY EH et al. Fibromyalgia syndrome module at OMER-ACT 9: domain construct. J Rheumatol 2009;36:2318-29.
8. CHOY EH, ARNOLD LM, CLAUW DJ et al. Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome (abstract). J Rheumatol 2009;36:2330-4.
9. STUTTS LA, ROBINSON ME, MCCULLOCH RC et al.: Patient-centered outcome criteria for successful treatment of facial pain and fibromyalgia (abstract). J Orofac Pain 2009;23:47-53.
10. ARNOLD LM, CROFFORD U, MEASE PJ et al.: Patient perspectives on the impact of fibromyalgia (abstract). Patient Educ Couns 2008;73:114-20.
11. PARRISH BP, ZAUTRA AJ, DAVIS MC: The role of positive and negative interpersonal events on daily fatigue in women with fibromyalgia, rheumatoid arthritis, and osteoarthritis. Health Psychol 2008;27:694-702.
12. UCEYLER N, HAUSER W, SOMMER C: A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome. Arthritis Rheum 2008;59:1279-98.
13. SARZI-PUTTINI P, ATZENI F, DI FRANCO M et al.: Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndrome. Autoimmunity 2008;41:74-9.
14. CHOY EH, MEASE PJ: Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials) (abstract). Rheum Dis Clin North Am 2009;35:329-37.
15. MEASE PJ, RUSSELL IJ, ARNOLD LM et al.: A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia (abstract). J Rheumatol 2008;35:502-14. (Pubitemid 351374429)
16. BERGMAN MJ, SHAHOURI SS, SHAVER TS et al.: Is fatigue an inflammatory variable in rheumatoid arthritis (RA) ? Analyses of fatigue in RA, osteoarthritis, and fibromyalgia. J Rheumatol 2009;36:2788-94.
17. CLAUW DJ, MEASE P, PALMER RH, GENDREAU RM, WANG Y: Milnacipran for the treatment of fibromyalgia in adults: a 15-week.multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008;30:1988-2004.
18. LORIG KR, RITTER PL, LAURENT DD, PLANT K: The internet-based arthritis self-management program: a one-year randomized trial for patients with arthritis or fibromyalgia. Arthritis Rheum 2008;59:1009-17. (Pubitemid 351990999)
19. DHIR V, LAWRENCE A, AGGARWAL A, MISRA R: Fibromyalgia is common and adversely affects pain and fatigue perception in North Indian patients with rheumatoid arthritis. J Rheumatol 2009;36:2443-8.
20. ALENTORN-GELI E, PADILLA J, MORAS G, LAZARO HC, FERNANDEZ-SOLA J: Six weeks of whole-body vibration exercise improves pain and fatigue in women with fibromyalgia. J Altern Complement Med 2008;14:975-81.
21. CHEN KW, HASSETT AL, HOU F, STALLER J, LICHTBROUN AS: A pilot study of external qigong therapy for patients with fibromyalgia. J Altern Complement Med 2006;12:851-6. (Pubitemid 44770976)
22. PASSARD A, ATTAL N, BENADHIRA R et al.: Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic widespread pain in fibromyalgia. Brain 2007;130:2661-70. (Pubitemid 47511708)
23. ERICSSON A, MANNERKORPI K: Assessment of fatigue in patients with fibromyalgia and chronic widespread pain. Reliability and validity of the Swedish version of the MFI-20 (abstract). Disabil Rehabil 2007;29:1665-70. (Pubitemid 351485786)
24. DA COSTA D, DRITSA M, BERNATSKY S et al.: Dimensions of fatigue in systemic lupus erythematosus: relationship to disease status and behavioral and psychosocial factors (abstract). J Rheumatol 2006;33:1282-8. (Pubitemid 44025141)
25. TROJAN DA, ARNOLD DL, SHAPIRO S et al.: Fatigue in post-poliomyelitis syndrome: association with disease-related, behavioral, and psychosocial factors. PMR 2009;1:442-9.
26. Measurement of fatigue in systemic lupus erythematosus: a systematic review (abstract). Arthritis Rheum 2007;57:1348-57.
27. CHAIAMNUAY S, BERTOLI AM, FERNANDEZ M et al.: The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected]. J Clin Rheumatol 2007;13:128-33. (Pubitemid 46884199)
28. HUSTED JA, TOM BD, SCHENTAG CT, FAREWELL VT, GLADMAN DD: Occurrence and correlates of fatigue in psoriatic arthritis. Ann Rheum Dis 2009;68:1553-8.
29. DE TOMMASO M, SARDARO M, SERPINO C et al.: Fibromyalgia comorbidity in primary headaches. Cephalalgia 2009;29:453-64.
30. THIMINEUR M, DE RIDDER D: C2 area neurostimulation: a surgical treatment for fibromyalgia (abstract). Pain Med 2007;8:639-46. (Pubitemid 350142911)
31. SALAFFI F, SARZI-PUTTINI P, GIROLIMETTI R, GASPARINI S, ATZENI F, GRASSI W: Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect (abstract). Arthritis Res Ther 2009;11:R125.
32. EYIGOR S, KARAPOLAT H, KORKMAZ OK et al.: The frequency of fibromyalgia syndrome and quality of life in hospitalized cancer patients (abstract). Eur J Cancer Care (Engl) 2009;18:195-201.
33. ASSUMPCAO A, CAVALCANTE AB, CAPELA CE et al.: Prevalence of fibromyalgia in a low socioeconomic status population. BMC Musculoskelet Disord 2009;10:64.
34. SUTBEYAZ ST, SEZER N, KOSEOGLU F, KIBAR S: Low-frequency pulsed electromagnetic field therapy in fibromyalgia: a randomized, double-blind, sham-controlled clinical study. Clin J Pain 2009;25:722-8.
35. RELTON C, SMITH C, RAW J et al.: Healthcare provided by a homeopath as an adjunct to usual care for Fibromyalgia (FMS): results of a pilot Randomised Controlled Trial. Homeopathy 2009;98:77-82.
36. SADREDDINI S, MOLAEEFARD M, NOSHAD H, ARDALAN M, ASADI A: Efficacy of Raloxifen in treatment of fibromyalgia in menopausal women. Eur J Intern Med 2008;19:350-5. (Pubitemid 351783396)
37. SAUTTER NB, MACE J, CHESTER AC, SMITH TL: The effects of endoscopic sinus surgery on level of fatigue in patients with chronic rhinosinusitis. Am J Rhinol 2008;22:420-6.
38. WHITEHEAD L: The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manage 2009;37:107-28.
39. US FOOD AND DRUG ADMINISTRATION: SOLIRIS (Brand Name Drug). 6-30-2008. 2-1-2010.
40. KATZ RS, WOLFE F, MICHAUD K: Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 2006;54:169-76. (Pubitemid 43122199)
41. CHARMAZ K: Grounded Theory. In: SMITH JA, HARRE R, VAN LANGENHOVE L (Eds.), Rethinking Methods in Psychology, pp. 27-49. London: Sage, 1995.
42. GLASER B, STRAUSS AL: The constant comparative methods of qualitative analysis. Discovery of Grounded Theory pp. 101-116. 1967. New York, Aldine de Gruyter.
43. STRAUSS A, CORBIN J: Basics of Qualitative Research: Techniques and Procesdures for Developing Grounded Theory. London: Sage, 1998.
44. MUHR T: User's Manual for Atlas.ti 5.0 Berlin: Atlaşti. (5.0). 2004. Berlin. 1-1-2004.
45. BOWEN GA: Grounded theory and sensitizing concepts. International Journal of Qualitative Methods 2006;5:12-23.
46. GORUSCH R: Factor Analysis, Hillsdale, NJ: Lawrence Erlbaum Associates, 1983.
47. NUNNALLY J: Psychometric Theory. New York: McGraw Hill, 1978.
48. BURCKHARDT CS, CLARK SR, BENNETT RM: The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991;18:728-33.
49. BENNETT R: The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005;23:S154-62. (Pubitemid 46657522)
50. WEAVER TE, LAIZNER AM, EVANS LK et al.: An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997;20:835-43. (Pubitemid 27524711)
51. HINKLE, WERSMA: Applied statistics for the behavioral sciences. Chicago: McNally College Publication, 1979.
52. ANGST F, AESCHLIMANN A, STUCKI G: Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum 2001;45:384-91. (Pubitemid 32738745)
53. GUYATT GH, OSOBA D, WU AW, WYRWICH KW, NORMAN GR: Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77:371-83. (Pubitemid 34260746)
54. KOSINSKI M, ZHAO SZ, DEDHIYA S, OSTERHAUS JT, WARE JE, Jr.: Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 2000;43:1478-87. (Pubitemid 30452465)
55. KUJAWSKI SC, KOSINSKI M, MARTIN R, WANKE LA, BUATTI MC, WARE JE: Determining meaningful improvement in SF-36 scale scores for treatment studies of early, active RA. Arthritis Rheum 2000;43:S140
56. THUMBOO J, FONG KY, NG TP et al.: Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. J Rheumatol 1999;26:97-102. (Pubitemid 29051403)
57. WELLS GA, TUGWELL P, KRAAG GR, BAKER PR, GROH J, REDELMEIER DA: Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol 1993;20:557-60. (Pubitemid 23102493)
58. WYRWICH KW, NIENABER NA, TIERNEY WM, WOLINSKY FD: Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999;37:469-78.
59. WYRWICH KW, TIERNEY WM, WOLINSKY FD: Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 1999;52:861-73. (Pubitemid 29385600)
60. ZHAO SZ, MCMILLEN JI, MARKENSON JA et al.: Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxib. Pharmacotherapy 1999;19:1269-78.
61. ALTMAN DG: Practical statistics for medical research. London: Chapman & Hall CRC, 1991.
62. RUSSELL IJ, HOLMAN A, SWICK T et al.: Sodium Oxybate Reduces Pain, Fatigue, and Sleep Disturbance and Improves Functionality in Fibromyalgia: Results from a 14-Week, Randomized, Double-Blind, Placebo-Controlled Study. Unknown 2010; Under Review.
63. TURK D, MELZACK R: Handbook of Pain Assessment. New York: Guilford Press, 2001.
64. BENNETT RM, FRIEND R, JONES KD, WARD R, HAN BK, ROSS RL: The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 2009;11:R120.